Mog001 50553

Washington D.C., District of Columbia 20057

0 studies enrolling now · 1 studies all time

What they study most

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOGAD) — Running, not enrolling